Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenofovir DF versus emtricitabine + tenofovir DF in lamivudine-resistant chronic hepatitis B
2008-001464-36Phase 3Completed
- Sponsor
- Gilead Sciences
- Start
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of tenofovir disoproxil fumarate and emtricitabine in Chronic Hepatitis B (CHB) (2 arms), sponsored by Gilead Sciences. Started Aug 2008; status: completed.
02
Drugs
tenofovir disoproxil fumarateemtricitabine
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on 2008-001464-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001464-36.